1. Home
  2. SMID vs ALEC Comparison

SMID vs ALEC Comparison

Compare SMID & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$30.94

Market Cap

157.6M

Sector

Industrials

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.51

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
ALEC
Founded
1960
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.6M
158.8M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
SMID
ALEC
Price
$30.94
$1.51
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.83
AVG Volume (30 Days)
11.6K
518.5K
Earning Date
04-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
0.25
N/A
Revenue
$93,446,000.00
$21,045,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$29.87
P/E Ratio
$121.12
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$1.09
52 Week High
$43.62
$3.40

Technical Indicators

Market Signals
Indicator
SMID
ALEC
Relative Strength Index (RSI) 56.37 41.58
Support Level $28.01 $1.37
Resistance Level $31.21 $1.60
Average True Range (ATR) 1.11 0.12
MACD 0.19 -0.00
Stochastic Oscillator 69.13 25.44

Price Performance

Historical Comparison
SMID
ALEC

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: